Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
10.78 USD | +0.14% | -2.30% | -49.91% |
Financials (USD)
Sales 2024 * | 41.78M | Sales 2025 * | 125M | Capitalization | 648M |
---|---|---|---|---|---|
Net income 2024 * | -394M | Net income 2025 * | -330M | EV / Sales 2024 * | 3.47 x |
Net cash position 2024 * | 503M | Net cash position 2025 * | 330M | EV / Sales 2025 * | 2.54 x |
P/E ratio 2024 * |
-1.66
x | P/E ratio 2025 * |
-2.08
x | Employees | 487 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 87.53% |
Latest transcript on Sage Therapeutics, Inc.
1 day | -1.82% | ||
1 week | -6.35% | ||
Current month | -3.06% | ||
1 month | -18.72% | ||
3 months | -49.03% | ||
6 months | -48.35% | ||
Current year | -50.30% |
Managers | Title | Age | Since |
---|---|---|---|
Barry Greene
CEO | Chief Executive Officer | 60 | 20-09-30 |
Steven Paul
FOU | Founder | 73 | 10-04-15 |
Kimi Iguchi
DFI | Director of Finance/CFO | 61 | 13-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeff Jonas
BRD | Director/Board Member | 71 | 13-08-13 |
Steven Paul
FOU | Founder | 73 | 10-04-15 |
Barry Greene
CEO | Chief Executive Officer | 60 | 20-09-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.13% | 14 M€ | -3.61% | ||
0.21% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 10.86 | +0.83% | 58 141 |
24-06-06 | 10.77 | -1.82% | 645,554 |
24-06-05 | 10.97 | +2.72% | 921,597 |
24-06-04 | 10.68 | -3.87% | 1,674,625 |
24-06-03 | 11.11 | 0.00% | 1,171,885 |
Delayed Quote Nasdaq, June 06, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-50.30% | 648M | |
+19.33% | 125B | |
+13.95% | 108B | |
-3.53% | 24.57B | |
+3.41% | 22.82B | |
-10.44% | 18.19B | |
-41.48% | 16.54B | |
-12.62% | 16.5B | |
+0.99% | 13.39B | |
+21.79% | 11.1B |
- Stock Market
- Equities
- SAGE Stock